These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9263698

  • 1. Endometrial changes with chronic tamoxifen use.
    Loret de Mola JR.
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
    [Abstract] [Full Text] [Related]

  • 2. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F, Curcio C, Fasciani A, Giuntini A, Artini PG, Fornaciari G, Petraglia F, Genazzani AR.
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [Abstract] [Full Text] [Related]

  • 3. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I, Asakawa T, Ando Y, Shiraiwa M, Shibutani O, Akaki S, Kuroda M, Mizutani Y, Kudo T, Hiraki Y.
    Radiat Med; 1998 Mar; 16(4):315-9. PubMed ID: 9814431
    [Abstract] [Full Text] [Related]

  • 4. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF, Lin HH, Torng PL, Huang SC.
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [Abstract] [Full Text] [Related]

  • 5. The effects of tamoxifen treatment on the endometrium.
    Daniel Y, Inbar M, Bar-Am A, Peyser MR, Lessing JB.
    Fertil Steril; 1996 Jun; 65(6):1083-9. PubMed ID: 8641477
    [Abstract] [Full Text] [Related]

  • 6. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF, Maksimov SIa, Bulgatova EA, Meshkova IE, Chepik OF, Berstein LM.
    Vopr Onkol; 2003 Jun; 49(2):198-204. PubMed ID: 12785205
    [Abstract] [Full Text] [Related]

  • 7. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV, Maksimov SIa, Barash NIu, Berstein LM, Semiglazov VF, Sheĭko EV, Novik VI.
    Vopr Onkol; 1998 Jun; 44(2):170-4. PubMed ID: 9615821
    [Abstract] [Full Text] [Related]

  • 8. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
    Schlesinger C, Kamoi S, Ascher SM, Kendell M, Lage JM, Silverberg SG.
    Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
    [Abstract] [Full Text] [Related]

  • 9. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F.
    Cancer; 1998 May 01; 82(9):1698-703. PubMed ID: 9576291
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen and endometrial cancer.
    Segna RA, Dottino PR, Deligdisch L, Cohen CJ.
    Mt Sinai J Med; 1992 Oct 01; 59(5):416-8. PubMed ID: 1435840
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 12. [The effects of tamoxifen on the female genital tract].
    Mourits MJ, van der Zee AG, Willemse PH, Hollema H, de Vries EG.
    Ned Tijdschr Geneeskd; 2003 Nov 22; 147(47):2315-20. PubMed ID: 14669536
    [Abstract] [Full Text] [Related]

  • 13. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
    Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Coibion M, Bianco AR.
    Hum Reprod; 2006 Feb 22; 21(2):545-53. PubMed ID: 16210385
    [Abstract] [Full Text] [Related]

  • 14. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P, Vergote I.
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun 22; 15(3):365-80. PubMed ID: 11476559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F.
    Gynecol Oncol; 2000 Aug 22; 78(2):181-6. PubMed ID: 10926800
    [Abstract] [Full Text] [Related]

  • 17. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
    Saadat M, Truong PT, Kader HA, Speers CH, Berthelet E, McMurtrie E, Olivotto IA.
    Cancer; 2007 Jul 01; 110(1):31-7. PubMed ID: 17510927
    [Abstract] [Full Text] [Related]

  • 18. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
    Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J.
    Cancer; 2006 Sep 01; 107(5):950-8. PubMed ID: 16865680
    [Abstract] [Full Text] [Related]

  • 19. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D, Horn LC.
    Zentralbl Gynakol; 2002 Jan 01; 124(1):3-9. PubMed ID: 11873307
    [Abstract] [Full Text] [Related]

  • 20. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.